GlassScriptPhysician profile
James S Yoon
NPI 1083041503
$1,663.33
in general payments reported to CMS, 2019-2025
17 companies · $588 in 2025
The $588 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $242 · 2021: $103 · 2023: $428 · 2024: $138 · 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,154.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $260.71 | 2019-2025 | Arexvy, Shingrix, Bexsero |
| Astrazeneca Pharmaceuticals LP | $249.99 | 2020-2023 | Farxiga |
| Sanofi-Aventis U.S. LLC | $175.82 | 2023-2025 | |
| Mayne Pharma Commercial LLC | $164.99 | 2025 | |
| Dexcom, INC. | $153.60 | 2025 | Dexcom G6 Transmitter |
| Boston Scientific Corporation | $127.68 | 2020-2021 | |
| Amgen INC. | $119.20 | 2020-2025 | Otezla, Repatha |
| Novo Nordisk INC | $84.53 | 2019-2024 | Wegovy |
| Theratechnologies INC. | $58.56 | 2023 | Egrifta, Trogarzo |
| Lilly USA, LLC | $44.04 | 2024-2025 | Mounjaro, Zepbound, Trulicity |
| Pfizer INC. | $42.33 | 2019-2025 | |
| Sanofi Pasteur INC. | $39.48 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.15 | 2025 | Jardiance |
| Merck Sharp & Dohme LLC | $34.00 | 2024 | |
| Novartis Pharmaceuticals Corporation | $24.91 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $24.14 | 2025 | Neffy |
| Hologic Sales and Service, LLC | $21.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Yoon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.